Loading...

CCEL

Cryo-Cell International, Inc. · AMEX

Performance

-2.37%

1W

-18.14%

1M

-1.33%

3M

+43.55%

6M

+28.7%

YTD

+26.06%

1Y

Profile

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Technical Analysis of CCEL 2024-05-31

Overview:

In analyzing the technical indicators for CCEL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and predictions for informed decisio...

See more ...

Recent News & Updates